Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

BeOne Medicines and partners renew Brukinsa access programme for CLL

Aug 19, 2026, 7:49 AM

Read Full Article → BeOne Medicines and partners renew Brukinsa access programme for CLL

BeOne Medicines and partners renew Brukinsa access programme for CLL

Translate article text

Choose a language and wait for the translated text.

BeOne Medicines, the BeOne Care Foundation, and The Max Foundation have extended their Brukinsa access programme for CLL until 2028.

BeOne Medicines and partners renew Brukinsa access programme for CLL | PharmaVoice